Zusammenfassung
Hintergrund: Wir analysierten die Befunde und Sehschärfe sowie mögliche Einflussfaktoren nach Vitrektomie bei Patienten mit diabetischem zystoiden Makulaödem. Material und Methoden: In einer prospektiven Studie wurde eine Pars-plana-Vitrektomie bei 62 Patienten mit einem diabetischen zystoiden Makulaödem und insgesamt 72 Augen durchgeführt, bei denen eine Laserkoagulation erfolglos geblieben war. Eine vitreomakuläre Traktion fand sich biomikroskopisch, mittels eines B-Scan-Ultraschalls sowie mittels der optischen Kohärenz-Tomographie bei 21 Augen, 15 Augen wiesen eine komplette hintere Glaskörperabhebung (PVD) auf und 36 Augen eine partielle periphere PVD. Es wurde eine Vitrektomie mit vitreomakulären tangentiellen Auflockerungen und axialen Traktionskräften durchgeführt. Alle Patienten wurden mindestens 6 Monate lang nachbeobachtet. Ergebnisse: Die anatomischen Ergebnisse waren bei 69 von 72 Augen zufriedenstellend (96 %), der postoperative Visus verbesserte sich um zwei und mehr Zeilen bei 45 von 72 Augen (63 %), blieb gleich bei 22 von 72 Augen (31 %) und verschlechterte sich bei 5 von 72 Augen (7 %). Die Verschlechterung war bedingt durch ein zystoides Makulaödem sowie durch extrem große harte Makulaexsudate. Die besten Ergebnisse wurden beim Ödem mit überwiegend traktionellem Charakter beobachtet sowie bei Augen mit einem zystoiden Makulaödem von weniger als 6 Monaten Dauer. Schlussfolgerungen: Die Vitrektomie zur Behandlung des diabetischen zystoiden Makulaödems ist eine effektive Methode, um das Ödem zu reduzieren und um die Sehschärfe zu verbessern. Die Operation war von Nutzen nicht nur bei Augen mit vitreomakulärer Traktion, sondern auch bei Augen mit kompletter PVD. Die Verbesserung der Sehschärfe nach einer Vitrektomie hängt von der Ödemdauer ab, wobei der Operationszeitpunkt den entscheidenden prognostischen Faktor darstellt.
Abstract
Background: We evaluated visual outcomes after vitrectomy for diabetic cystoid macular edema and factors possibly influencing final visual acuity. Materials and Methods: Studied prospectively, pars plana vitrectomy was performed on 72 consecutive eyes of 61 patients with diabetic cystoid macular edema not responsive to laser photocoagulation therapy. Vitreomacular traction was observed on biomicroscopy, B-scan ultrasonography, and optical coherence tomography in 21 eyes, 15 eyes had a complete posterior vitreous detachment (PVD) and 36 eyes had partial peripheral PVD. Vitrectomy with releasing vitreomacular tangential and axial tractional forces was performed. All patients were followed up for at least 6 months. Results: The anatomical results were satisfactory in 69 of 72 eyes (96 %), the final visual acuity improved by 2 or more lines in 45 of 72 eyes (63 %), remained unchanged in 22 of 72 eyes (31 %), and deteriorated after surgery in 5 of 72 eyes (7 %), due to residual cystoid macular edema and massive macular hard exudates. The best results were obtained in edema with tractional predominance and in eyes with a duration of cystoid macular edema shorter than 6 months. Conclusions: Vitrectomy for diabetic cystoid macular edema is an effective procedure for reducing the edema and improving visual acuity. Surgery was beneficial not only in eyes with vitreomacular traction but also in eyes with complete PVD. Visual improvement after vitrectomy is related to duration of edema, therefore the timing of the surgery is an important prognostic factor.
Schlüsselwörter
Diabetisches Makulaödem - makulare Laserkoagulation - Pars-plana-Vitrektomie
Key words
Diabetic macular edema - macular laser photocoagulation - pars plana vitrectomy
Literatur
-
1
Aiello L P.
Clinical implications of vascular endothelial growth factors in proliferative retinopathy.
Curr Opin Ophthalmol.
1997;
8
19-31
-
2
Benz M, Murray T, Dubovy S. et al .
Endophthalmitis caused by Mycobacterium chelonae abscessus after intravitreal injection of triamcinolone.
Arch Ophthalmol.
2003;
121
271-273
-
3
Blankenship G.
Diabetic macular edema and argon laser photocoagulation: a prospective randomized study.
Ophthalmology.
1979;
86
69-78
-
4
Bresnick G H.
Diabetic maculopathy. A critical review highlighting diffuse macular edema.
Ophthalmology.
1983;
90
1301-1317
-
5
Bresnick G H.
Diabetic macular edema: a review.
Ophthalmology.
1986;
93
989-997
-
6
Brooks H L Jr.
Macular hole surgery with and without internal limiting membrane peeling.
Ophthalmology.
2000;
107
1939-1949
-
7
Collins P D, Connolly D T, Williams T J.
Characterization of the increase in vascular permeability induced by vascular permeability factor in vivo.
Br J Pharmacol.
1993;
109
195-199
-
8
Connolly D T.
Vascular permeability factor: a unique regulator of blood vessel function.
J Cell Biochem.
1991;
47
219-223
-
9
Early Treatment Diabetic Retinopathy Study Group .
Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report No. 1.
Arch Ophthalmol.
1985;
103
1796-1806
-
10
Early Treatment Diabetic Retinopathy Study Research Group .
Focal photocoagulation treatment of diabetic macular edema. Relationship of treatment effect to flourescein angiographic and other retinal characteristics at baseline: ETDRS report no. 19.
Arch Ophthalmol.
1995;
113 (9)
1144-1155
-
11
Enaida H, Sakamoto T, Hisatomi T. et al .
Morphological and functional damage of the retina caused by intravitreous indocyanine green in rat eyes.
Graefe’s Arch Clin Exp Ophthalmol.
2002;
240 (3)
243-246
-
12
Ferris F L, Patz A.
Macular oedema. A complication of diabetic retinopathy.
Surv Ophthalmol.
1984;
28
S452-S461
-
13
Gandorfer A, Messmer E M, Ulbig M W. et al .
Resolution of diabetic macular oedema after surgical removal of the posterior hyaloid and the inner limiting membrane.
Retina.
2000;
20
126-133
-
14
Gandorfer A, Messmer E M, Ulbig M W. et al .
Indocyanine green selectively stains the internal limiting membrane.
Am J Ophthalmol.
2001;
131
387-388
-
15 Gass J DM. Macular dysfunction caused by retinal vascular disorders. Craven L Stereoscopic atlas of macular diseases: diagnosis and treatment, 3rd edn St. Louis; Mosby 1987: 333-354
-
16
Harbour J W, Smiddy W E, Flynn H W. et al .
Vitrectomy for diabetic macular oedema associated with a thickened and taut posterior hyaloid membrane.
Am J Ophthalmol.
1996;
121
405-413
-
17
Haritoglou C, Gandorfer A, Gass C A. et al .
The effect of indocyanine-green on functional outcome of macular pucker surgery.
Am J Ophthalmol.
2003;
135 (3)
328-337
-
18
Hofman P, Van Blijswijk B C, Gaillard P J. et al .
Endothelial cell hypertrophy induced by vascular endothelial growth factor in the retina: new insights into the pathogenesis of capillary nonperfusion.
Arch Ophthalmol.
2001;
119
861-866
-
19
Hykin P, Shields C, Shields J. et al .
The efficacy of focal laser therapy in radiation-induced macular edema.
Ophthalmology.
1998;
105
1425-1429
-
20
Ikeda T, Sato K, Katano T. et al .
Attached posterior hyaloid membrane and the pathogenesis of honeycomb cystoid macular oedema in patients with diabetes.
Am J Ophthalmol.
1999;
127
478-479
-
21
Ikeda T, Sato K, Katano T. et al .
Vitrectomy for cystoid macular oedema with attached posterior hyaloid membrane in patients with diabetes.
Br J Ophthalmol.
1999;
83
2-14
-
22
Ikeda T, Sato K, Katano T. et al .
Improved visual acuity following pars plana vitrectomy for diabetic cystoid macular edema and detached posterior hyaloid.
Retina.
2000;
20 (2)
220-222
-
23
Jonas J, Kreissig I, Degenring R.
Intraocular pressure after intravitreal injection of triamcinolone acetonide.
Br J Ophthalmol.
2003;
87
24-27
-
24
Kalvodova B, Zahlava J.
Results of vitrectomy in cystoid diabetic macular edema detected by optical coherence tomography.
Cesk Slov Oftalmol.
2002;
58 (4)
224-232
-
25
Klein R, Klein B, Moss S. et al .
The Wisconsin Epidemiologic Study of Diabetes. IV. Diabetic macular edema.
Ophthalmology.
1984;
91
1464-1474
-
26
Kuhn F, Kiss G, Mester V. et al .
Vitrectomy with internal limiting membrane removal for clinically significant macular oedema.
Graefe’s Arch Clin Exp Ophthalmol.
2004;
242
402-408
-
27
Kumagai K, Ogino N, Furukawa M. et al .
Internal limiting membrane peeling in vitreous surgery for diabetic macular edema.
Nippon Ganka Gakkai Zasshi.
2002;
106
590-594
-
28
La H eij EC, Hendrikse F, Kessels A G. et al .
Vitrectomy results in diabetic macular edema without evident vitreomacular traction.
Graefe’s Arch Clin Exp Ophthalmol.
2001;
239 (4)
264-270
-
29
Lewis H, Abrams G W, Blumenkranz M S.
Vitrectomy for diabetic macular traction and edema associated with posterior hyaloid traction.
Ophthalmology.
1992;
99
753-759
-
30
McDonald H R, Schatz H.
Grid photocoagulation of diffuse macular edema.
Retina.
1985;
5
65-72
-
31
Miller J W, Adamis A P, Shima D T. et al .
Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model.
Am J Pathol.
1994;
145
574-584
-
32
Moss S E, Klein R, Klein B E.
The incidence of vision loss in a diabetic population.
Ophthalmology.
1988;
95 (10)
1340-1348
-
33
Nasrallah F P, Jalkh A E, van Coppenrole F. et al .
The role of the vitreous in diabetic macular oedema.
Ophthalmology.
1988;
95
1335-1339
-
34
Olk R J.
Modified grid argon (blue-green) laser photocoagulation for diffuse diabetic macular edema.
Ophthalmology.
1986;
93
938-950
-
35
Otani T, Kishi S.
Tomographic assessment of vitreous surgery for diabetic macular edema.
Am J Ophthalmol.
2000;
129 (4)
487-494
-
36
Otani T, Kishi S.
A controlled study of vitrectomy for diabetic macular edema.
Am J Ophthalmol.
2002;
134
214-219
-
37
Otani T, Kishi S, Marruyama Y.
Patterns of diabetic macular oedema with optical coherence tomography.
Am J Ophthalmol.
1999;
127
688-693
-
38
Park D, Schatz H, McDonald H.
Grid laser photocoagulation for macular edema in bilateral juxtafoveal telangiectasis.
Ophthalmology.
1997;
104
1838-1846
-
39
Pendergast S D.
Vitrectomy for diabetic macular edema associated with a taut premacular posterior hyaloid.
Curr Opin Ophthalmol.
1998;
9
71-75
-
40
Pendergast S D, Hassan T S, Williams G A. et al .
Vitrectomy for diffuse diabetic macular edema associated with a taut premacular posterior hyaloid.
Am J Ophthalmol.
2000;
130 (2)
178-186
-
41
Radetzky S, Walter P, Fauser S. et al .
Visual outcome of patiens with macular edema after pars plana vitrectomy and indocyanine green-assisted peeling of the internal limiting membrane.
Graefe’s Arch Clin Exp Ophthalmol.
2004;
242
273-278
-
42
Sander B, Larsen M, Engler C. et al .
Diabetic macular oedema: a comparison of vitreous fluorometry, angiography, and retinopathy.
Br J Ophthalmol.
2002;
86 (3)
316-320
-
43
Sato Y, Lee Z, Shimada H.
Vitrectomy for diabetic cystoid macular edema.
Jap J Ophthalmol.
2002;
46
315-322
-
44
Schepens C L, Avila M P, Jalkh A E. et al .
Role of the vitreous in cystoid macular edema.
Surv Ophthalmol.
1984;
28 (suppl)
499-504
-
45
Sippy B D, Engelbrecht N E, Hubbard G B.
Indocyanine green effect on cultured human retinal pigment epithelial cells: Implication for macular hole surgery.
Am J Ophthalmol.
2001;
132
433-435
-
46
Stefaniotou M, Aspiotis M, Kalogeropoulos C. et al .
Vitrectomy results for diffuse diabetic macular edema with and without inner limiting membrane removal.
Eur J Ophthalmol.
2004;
14 (2)
137-143
-
47
Stefansson E, Novack R L, Hatchell D L.
Vitrectomy prevents retinal hypoxia in branch retinal vein occlusion.
Invest Ophthalmol Vis Sci.
1990;
31
284-289
-
48
Tachi N, Ogino N.
Vitrectomy for diffuse macular edema in cases of diabetic retinopathy.
Am J Ophthalmol.
1996;
122
258-260
-
49
Takagi H, Otani A, Kiryu J. et al .
New surgical approach for removing massive foveal hard exudates in diabetic macular edema.
Ophthalmology.
1999;
106 (2)
249-256; 256 - 257
-
50
Takaya K, Suzuki Y, Mizutani H. et al .
Long-term results of vitrectomy for removal of submacular hard exudates in patients with diabetic maculopathy.
Retina.
2004;
24 (1)
23-29
-
51 Tano Y. Vitrectomy for diabetic macular edema. American Academy of Ophthalmology, Subspecialty day Retina 2000: Management of posterior segment disease 2000; 1: 43-145 (data on CD)
-
52
Vinores S A, Derevjanik N L, Mahlow J. et al .
Electron microscopic evidence for the mechanism of blood- retinal barrier breakdown in diabetic rabbits: comparison with magnetic resonance imaging.
Pathol Res Pract.
1998;
194
497-505
-
53
Weinberger A W, Kirchhof B, Mazinani B E. et al .
Persistent indocyanine green (ICG) fluorescence 6 weeks after intraocular ICG administration for macular hole surgery.
Graefe’s Arch Clin Exp Ophthalmol.
2001;
239 (5)
388-390
-
54
Yamaguchi Y, Otani T, Kishi S.
Resolution of diabetic cystoid macular edema associated with spontaneous vitreofoveal separation.
Am J Ophthalmol.
2003;
135
116-118
-
55
Yamamoto T, Akabane N, Takeuchi S.
Vitrectomy for diabetic macular edema: the role of posterior vitreous detachment and epimacular membrane.
Am J Ophthalmol.
2001;
132 (3)
369-377
-
56
Yamamoto T, Hitani K, Tsukahara I. et al .
Early postoperative retinal thickness changes and complications after vitrectomy for diabetic macular edema.
Am J Ophthalmol.
2003;
135
14-19
-
57
Yoon K C, Seo M S.
Macular hole after peeling of the internal limiting membrane in diabetic macular edema.
Ophthalmic Surg Lasers Imaging.
2003;
34 (6)
478-479
MU Dr. Tarek Aboutable
Augenklinik, Allgemeines Fakultätskrankenhaus
U nemocnice 2
Prag 2, 12808
Tschechien
Telefon: ++ 4 20/6 05 77 05 06
Fax: ++ 4 20/2 24 91 86 50
eMail: tarek.a@seznam.cz
